Cite

HARVARD Citation

    Cybulska-Stopa, B. et al. (2023). Long-term clinical evidence of comparable efficacy and toxicity of nivolumab and pembrolizumab in advanced melanoma treatment. Melanoma research. 33 (3), pp. 208-217. [Online]. 
  
Back to record